Detailed answers about INOVATIAN PHARMACEUTICAL LIMITED, including incorporation, status, business activity, and accounts information.
When was INOVATIAN PHARMACEUTICAL LIMITED founded?
INOVATIAN PHARMACEUTICAL LIMITED was officially incorporated on 5 November 2024 and is registered under company number 16061059. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is INOVATIAN PHARMACEUTICAL LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of INOVATIAN PHARMACEUTICAL LIMITED?
INOVATIAN PHARMACEUTICAL LIMITED's current status is Active - Proposal to Strike off. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does INOVATIAN PHARMACEUTICAL LIMITED do?
INOVATIAN PHARMACEUTICAL LIMITED operates in the following sectors: 21100 - Manufacture of basic pharmaceutical products, 21200 - Manufacture of pharmaceutical preparations, 46460 - Wholesale of pharmaceutical goods, 72110 - Research and experimental development on biotechnology. These SIC codes provide insight into the company's business activities and industry focus.
What is INOVATIAN PHARMACEUTICAL LIMITED's registered address?
The registered office address of INOVATIAN PHARMACEUTICAL LIMITED is GLOUCESTER STREET, GLOUCESTER STREET, LONDON, ENGLAND, WC1N 3AX. This is the official address filed with Companies House for legal and statutory correspondence.
Is INOVATIAN PHARMACEUTICAL LIMITED financially stable?
Financial accounts for INOVATIAN PHARMACEUTICAL LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.